Company has both acquired office space and executed on strategic hiring initiatives.
Boston, MA October 12, 2021 – Labviva, a leader in healthcare procurement today announced the opening of its new headquarters at 164 Canal Street in Boston. The move is concurrent with a hiring initiative that will add over thirty new staff members over the next three quarters.
The Labviva platform is an enterprise gateway marketplace (EGM) that integrates with procurement solutions commonly used by the world’s largest pharmaceutical, biotechnology, and research institutions. Life sciences organizations can leverage applications such as SAP Ariba, JAGGAER, and Oracle Procurement Cloud. Labviva’s platform gives purchasers of laboratory supplies, consumables, reagents, and equipment the ability to source from any supplier in the Labviva network without onboarding individual catalogs. In addition, users have access to advanced analytics, sophisticated search, and comparison tools that help keep both research and spend targets on track.
New strategic personnel include:
Neala Cetola, Vice President of Customer Success. With experience at innovative brands like Drizly and mainstays like PayPal, Ms. Cetola brings a sophisticated understand of the customer journey to Labviva.
Julie Tagliamonte, Vice President Client and Customer Services. Ms. Tagliamonte has extensive experience in project management, mentoring teams and strategic account management and will head customer service.
Steve Tremblay, Vice President of Commercial Operations. Mr. Tremblay comes to Labviva with wide operational and finance experience that includes over a decade at the executive level.
Nick Herbold, Senior Director Platform Delivery. Mr. Herbold is graduate of Harvard Business School who has past experience at GrubHub, LevelUp, and Twitter.
Anita Wells, Director Business Development. Ms. Wells comes to Labviva from biotech and biopharma and brings broad sales, marketing, and operations experience.
Patricia Deeney, Senior Project Manager. Skilled in executing on the vision and leadership of programs for enterprise customers, Ms. Deeney will help Labviva operate at scale.
“We are excited to welcome the newest members of Labviva to our Boston office,” said Siamak Baharloo, CEO and Co-Founder of Labviva. “Talent is one of the most strategic assets of any organization, and I look forward to growing the company and our market reach with this team.”
“Our teams are currently spread across each continental US time zone,” said Aaron Miramontes, Chief Product Officer and Co-Founder of Labviva. “While we will continue to seek out top talent regardless of their location, we also believe that having a centralized office location will help us serve the needs of our customers.”
Labviva was founded in 2017 by life sciences industry veterans Baharloo, Aaron Miramontes, and Nicholas Rioux. The company raised over $2M in pre-seed funding in 2020, and in June of 2021 announced a capital raise of $8M.
All brands are the properties of their respective owners.
Labviva connects researchers with suppliers of reagents, chemicals, and instrumentation in an intuitive user-friendly platform that supports the priorities of scientists while staying compliant with purchasing rules. Suppliers can easily manage their content of their products, and products are mapped into scientific applications, techniques and protocols. Learn more about how Labviva accelerates the science of life at www.labviva.com